Press Releases

TORONTO--(BUSINESS WIRE)-- SunOpta Inc. (“SunOpta” or the “Company”) (Nasdaq:STKL) (TSX:SOY), a leading global company focused on organic, non-genetically modified and specialty foods, today announced financial results for the third quarter ended September 29, 2018. “We generated 2.0% adjusted revenue growth during the third quarter, led by our beverage, snack and organi

DUBLIN, Ohio--(BUSINESS WIRE)-- Navidea Biopharmaceuticals, Inc. (NYSE American: NAVB) (“Navidea” or the “Company”), a company focused on the development of precision immunodiagnostic agents and immunotherapeutics, today announced its financial results for the third quarter of 2018. Navidea reported total revenues for the quarter of $231,000. Net loss attributable to common stockholders

AUSTIN, Texas--(BUSINESS WIRE)-- CarStory, the automotive AI platform, today announced the launch of CarStory Vision, the first dedicated automotive visual search product for

LONDON & MUNICH--(BUSINESS WIRE)-- UiPath, the leading software provider for enterprise Robotic Process Automation (RPA), announced today that it was awarded the "Prize of the Jury" at

MILWAUKEE--(BUSINESS WIRE)-- Rockwell Automation, Inc. (NYSE: ROK) today reported fiscal 2018 fourth quarter sales of $1,729.5 million, up 3.7 percent from $1,667.5 million in the fourth quarter of fiscal 2017. Organic sales grew 7.3 percent. Currency translation reduced sales by 2.2 percentage points, and the prior year divestiture reduced sales by 1.4 percentage points. Fiscal 2018 fourth quarter n

TOKYO--(BUSINESS WIRE)-- Renesas Electronics Corporation (TSE:6723), a premier supplier of advanced semiconductor solutions, today announced a new family of automotive-grade 100V, 4A half-bridge N-channel MOSFET drivers. The ISL784x4 family features three devices: the ISL78424 and ISL78444 with single tri-level PWM input for controlling both gate drivers, and the ISL78434, which has dual independent inputs that

HOUSTON--(BUSINESS WIRE)-- NOW Inc. (NYSE: DNOW) announced today that Michael Frazier, a member of the NOW Inc. Board of Directors, has passed away. Mr. Frazier had been a director of the Company since May 2014. Mr. Frazier was with Simmons & Company International, an independent investment bank specializing in the energy industry, from 1992, and served as its President and Chief Executive Office

SAN JOSE, Calif.--(BUSINESS WIRE)-- Vocera Communications, Inc. (NYSE:VCRA), a recognized leader in clinical communication and workflow solutions, today anno

HOUSTON--(BUSINESS WIRE)-- IronClad Encryption Corporation (OTCQB: IRNC), a cyber defense company that secures digital assets and communications across

SKOKIE, Ill.--(BUSINESS WIRE)-- Exicure, Inc. (OTCQB:XCUR), the pioneer in gene regulatory and immunotherapeutic drugs utilizing three-dimensional spherical nucleic acid (SNA™) constructs, announced today plans to attend two investor conferences and two scientific conferences in November 2018. Exicure will be providing a corporate update November 14, from 3:30 to 4:10 pm EST at the Stifel He

MIAMI--(BUSINESS WIRE)-- EnviroStar, Inc. (NYSE American: EVI) announced today that it completed its merger with Lucken, Inc., the parent company of Washington Automated, Inc. (“WAI”) on November 6, 2018. WAI is a Washington-based distributor of commercial and vended laundry products and a provider of related installation and maintenance services to customers in the hospitality, healthcar

NEW YORK--(BUSINESS WIRE)-- Rocket Pharmaceuticals, Inc. (Nasdaq: RCKT) (“Rocket”), a leading U.S.-based multi-platform gene therapy company, r

ALAMEDA, Calif.--(BUSINESS WIRE)-- Wind River®, a leader in delivering IoT software for safety-critical domains including automotive, announced enhancements to

KENILWORTH, N.J.--(BUSINESS WIRE)-- Merck (NYSE:MRK), known as MSD outside the United States and Canada, today announced the first presentations of preliminary safety and efficacy data from Phase 1/2 dose finding studies for the company’s investigational anti-LAG-3 therapy (MK-4280) and anti-TIGIT therapy (MK-7684) in patients with advanced solid tumors. LAG-3 and TIGIT are negative immune regulators and

WILMINGTON, Mass.--(BUSINESS WIRE)-- Charles River Laboratories International, Inc. (NYSE: CRL) today reported its results for the third quarter of 2018. For the quarter, revenue was $585.3 million, an increase of 26.1% from $464.2 million in the third quarter of 2017. Revenue growth was driven by all three business segments, particularly the Discovery and Safety Assessment segment. Acquisitio